Aclarion

Aclarion, Inc. is a healthcare technology company located in Broomfield, Colorado, founded in 2008. The company develops noninvasive, evidence-based software-as-a-service (SaaS) solutions aimed at improving care for patients with chronic lower back pain. Aclarion utilizes magnetic resonance spectroscopy (MRS) and proprietary biomarkers to enhance clinical treatments, particularly through the analysis of intervertebral discs. The flagship product, NOCISCAN, employs MRS technology to analyze the chemical composition of spinal discs, aiding physicians in diagnosing and personalizing treatment plans for degenerative disc disease. Aclarion also offers the NOCISCAN MRS Exam Protocol, which enhances standard lumbar MRI exams, and various data transfer platforms, including AMBRA Healthcare and NOCIWEB. The NOCISCAN Post-Processor Suite includes NOCICALC, a medical device that processes MRS data, and NOCIGRAM, which quantifies degenerative pain biomarkers. Aclarion's solutions support physicians in delivering personalized treatment plans, ultimately aiming to improve clinical outcomes for patients suffering from back pain. The leadership team includes CEO Brent Ness and Executive Chairman Jeff Thramann, both experienced in medical device and healthcare technology.

• Employees 5
• Founded 2008
• Annual Revenue $54000
• Total Funding $28817750